Gustave Roussy, Cancer Campus, Grand Paris

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Radiofrequency Ablation of Lung Tumors

Phase 2

Completed

Conditions: Lung Cancer
Metastasis

First Posted Date: 2005-09-16

Last Posted Date: 2005-09-16

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 60

Registration Number: NCT00180856

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France
🇫🇷
Institut Bergonié, Bordeaux, France

Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia

Phase 3

Suspended

Conditions: Scheduled General Anesthesia

First Posted Date: 2005-09-16

Last Posted Date: 2005-09-16

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 128

Registration Number: NCT00181051

Locations: 🇫🇷
Institut Gustave-Roussy, Villejuif, France

Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children

Phase 3

Completed

Conditions: Osteosarcoma
Localised High Grade Osteosarcoma of the Limbs

First Posted Date: 2005-09-16

Last Posted Date: 2005-09-16

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 226

Registration Number: NCT00180908

Locations: 🇫🇷
Institut Gustave-Roussy, Villejuif, France

Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck

Phase 2

Conditions: Cancer of the Head and Neck
Carcinoma, Adenoid Cystic

First Posted Date: 2005-09-16

Last Posted Date: 2007-09-26

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 30

Registration Number: NCT00180921

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France

Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics

Phase 3

Conditions: Cancer
Pain

First Posted Date: 2005-09-16

Last Posted Date: 2007-09-19

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 100

Registration Number: NCT00181012

Locations: 🇫🇷
Institut Gustave-Roussy, Villejuif, France

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

Phase 2

Conditions: Medulloblastoma
Brain Tumors
Neuroectodermal Tumors, Primitive

First Posted Date: 2005-09-16

Last Posted Date: 2007-09-18

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 71

Registration Number: NCT00180791

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France

Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery

Phase 3

Conditions: Oropharyngeal Neoplasms

First Posted Date: 2005-09-16

Last Posted Date: 2007-08-28

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 40

Registration Number: NCT00181038

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France

Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course

Phase 3

Terminated

Conditions: - Medico-Economic Aspects (Evaluation of Medical Costs Related to the Three Strategies and Evaluation of Cost/Efficacy)

First Posted Date: 2005-09-16

Last Posted Date: 2006-09-11

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 420

Registration Number: NCT00180999

Locations: 🇫🇷
Institut Gustave-Roussy, Villejuif, France

Bevacizumab in Advanced Hepatocellular Carcinoma

Phase 2

Conditions: Hepatocellular Carcinoma

First Posted Date: 2005-09-13

Last Posted Date: 2006-09-08

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 50

Registration Number: NCT00162669

Locations: 🇫🇷
Institut Gustave Roussy, Villejuif, France

Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC

Phase 2

Completed

Conditions: Oropharynx Cancer
Oral Cancer
Hypopharynx Cancer
Larynx Cancer

First Posted Date: 2005-09-13

Last Posted Date: 2005-09-13

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 120

Registration Number: NCT00162708

Locations: 🇫🇷
Centre Alexis Vautrin, Nancy, France
🇫🇷
Centre Jean Perrin, Clermont-Ferrand, France
🇫🇷
Institut Gustave Roussy, Villejuif, France

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy